Journal
MOLECULAR CANCER
Volume 18, Issue -, Pages -Publisher
BMC
DOI: 10.1186/s12943-019-1008-0
Keywords
Pancreatic cancer; Microbiota; Microbiome; Inflammation; Metabolism; Immunotherapy; Tumor Microenvironment
Categories
Funding
- National Science Foundation for Distinguished Young Scholars of China [81625016]
- Shanghai Sailing Program [17YF1402500]
Ask authors/readers for more resources
Microbiota is just beginning to be recognized as an important player in carcinogenesis and the interplay among microbes is greater than expected. Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease for which mortality closely parallels incidence. Early detection would provide the best opportunity to increase survival rates. Specific well-studied oral, gastrointestinal, and intrapancreatic microbes and some kinds of hepatotropic viruses and bactibilia may have potential etiological roles in pancreatic carcinogenesis, or modulating individual responses to oncotherapy. Concrete mechanisms mainly involve perpetuating inflammation, regulating the immune system-microbe-tumor axis, affecting metabolism, and altering the tumor microenvironment. The revolutionary technology of omics has generated insight into cancer microbiomes. A better understanding of the microbiota in PDAC might lead tothe establishment of screening or early-stage diagnosis methods, implementation of cancer bacteriotherapy, adjustment of therapeutic efficacy even alleviating the adverse effects, creating new opportunities and fostering hope for desperate PDAC patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available